ALB and chronic kidney disease: In the CKD population, a few studies report the beneficial effect of HRT on reduced risk of CKD progression and all‐cause mortality in male patients with end‐stage kidney disease (Sharma et al., 2020) and reduced urinary albumin‐creatinine ratio cross‐sectionally in post‐menopausal female patients with CKD who used HRT vs. non‐users (Schopick et al., 2009).